ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31247-1mg |
|
128199-93-9 |
5-HT3 antagonist 2
|
0 | C18H21N3O | |
GC31246-20mg |
|
377727-26-9 |
Sch412348
|
0 | C22H21F2N9O | |
GC31246-10mg |
|
377727-26-9 |
Sch412348
|
0 | C22H21F2N9O | |
GC31246-5mg |
|
377727-26-9 |
Sch412348
|
0 | C22H21F2N9O | |
GC31246-1mg |
|
377727-26-9 |
Sch412348
|
0 | C22H21F2N9O | |
GC31245-25mg |
|
1675821-32-5 |
EML 425
|
0 | C27H24N2O4 | |
GC31245-10mg |
|
1675821-32-5 |
EML 425
|
0 | C27H24N2O4 | |
GC31245-5mg |
|
1675821-32-5 |
EML 425
|
0 | C27H24N2O4 | |
GC31244-20mg |
|
289893-23-8 |
Anti-neurodegeneration agent 1
|
0 | C14H20ClN3O3 | |
GC31244-10mg |
|
289893-23-8 |
Anti-neurodegeneration agent 1
|
0 | C14H20ClN3O3 | |
GC31244-5mg |
|
289893-23-8 |
Anti-neurodegeneration agent 1
|
0 | C14H20ClN3O3 | |
GC31244-1mg |
|
289893-23-8 |
Anti-neurodegeneration agent 1
|
0 | C14H20ClN3O3 | |
GC31243-25mg |
|
156719-41-4 |
S-MTC
|
0 | C7H15N3O2S | |
GC31243-10mg |
|
156719-41-4 |
S-MTC
|
0 | C7H15N3O2S | |
GC31243-5mg |
|
156719-41-4 |
S-MTC
|
0 | C7H15N3O2S | |
GC31242-20mg |
|
439153-64-7 |
LNK754
|
0 | C29H22ClN3O2 | |
GC31242-10mg |
|
439153-64-7 |
LNK754
|
0 | C29H22ClN3O2 | |
GC31242-5mg |
|
439153-64-7 |
LNK754
|
0 | C29H22ClN3O2 | |
GC31242-1mg |
|
439153-64-7 |
LNK754
|
0 | C29H22ClN3O2 | |
GC31241-1g |
|
488-82-4 |
D-Arabitol
|
0 | C5H12O5 | |